BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2427853)

  • 1. The effect of beta blockers on total peripheral resistance.
    Man in 't Veld AJ; van den Meiracker A; Schalekamp MA
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S49-60. PubMed ID: 2427853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the antihypertensive mechanisms of beta-adrenoceptor antagonists in relation to intrinsic sympathomimetic activity, cardioselectivity and hydrophilicity.
    Man in't Veld AJ; Schalekamp MA
    J Pharmacol; 1983; 14 Suppl 2():69-104. PubMed ID: 6138473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
    Lund-Johansen P; Omvik P
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive mechanisms of beta blockers.
    Conway J
    Eur Heart J; 1983 Jul; 4 Suppl D():43-51. PubMed ID: 6137382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions.
    Man in't Veld AJ; Van den Meiracker AH; Schalekamp MA
    Am J Hypertens; 1988 Jan; 1(1):91-6. PubMed ID: 2897200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.
    Man in 't Veld AJ; Schalekamp MA
    Eur Heart J; 1983 Jul; 4 Suppl D():31-41. PubMed ID: 6137381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of beta-blockade hypotension.
    Frohlich ED
    N Engl J Med; 1972 Dec; 287(24):1247-8. PubMed ID: 4404400
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of beta-adrenoceptor blockade on prostacyclin mediated renin release in sheep.
    Mason RT; Coghlan JP; Denton DA; Fei DW; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1984; 11(6):571-7. PubMed ID: 6152609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta blockers on vascular resistance in systemic hypertension.
    Man in 't Veld AJ
    Am J Cardiol; 1987 May; 59(13):21F-25F. PubMed ID: 2883873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade.
    Bakris G
    J Cardiovasc Pharmacol; 2009 May; 53(5):379-87. PubMed ID: 19454898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of beta-adrenergic blocking drugs in hypertension.
    Prichard BN; Owens CW
    Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilation, not cardiodepression, underlies the antihypertensive effect of beta-adrenoceptor antagonists.
    Man in 't Veld AJ
    Am J Cardiol; 1991 Apr; 67(10):13B-17B. PubMed ID: 1673579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers, autoregulation, and experimental design.
    Korner PI
    Hypertension; 1984; 6(2 Pt 1):140-4. PubMed ID: 6144631
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P
    Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanisms of antihypertensive action of beta-adrenergic receptor blocking drugs.
    Smits JF; Struyker-Boudier HA
    Clin Exp Hypertens A; 1982; 4(1-2):71-86. PubMed ID: 6122522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic vasoconstriction as a cause of inadequate hypotensive response to beta-adrenergic blockade.
    Birkenhäger WH; DeLeeuw PW
    Hypertension; 1983; 5(5 Pt 2):III31-5. PubMed ID: 6138310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocking agents with vasodilating action.
    Prichard BN
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S1-4. PubMed ID: 1378133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reduction of cardiac output--the principal effect of hypotensive agents].
    Kisin IE
    Kardiologiia; 1972 Feb; 12(2):152-7. PubMed ID: 4404553
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents.
    Colfer HT; Cottier C; Sanchez R; Julius S
    Hypertension; 1984; 6(2 Pt 1):145-51. PubMed ID: 6144632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.